Literature DB >> 15888670

In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on the prostate and its response to castration in senescent C57BL/6J mice.

Wayne A Fritz1, Tien-Min Lin, Robert W Moore, Paul S Cooke, Richard E Peterson.   

Abstract

In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure inhibits ventral, dorsolateral, and anterior prostate development in C57BL/6 mice. To determine if prostatic abnormalities persist into senescence, mice born to dams given TCDD (5 mug/kg, po) or vehicle on gestation day 13 were examined at 100 and 510 days of age. Half the mice were castrated ten days prior to necropsy in order to assess androgen dependence, while the remaining mice were sham castrated. Effects of TCDD on the dorsolateral and anterior prostate of senescent sham-castrated mice were relatively subtle, whereas the ventral prostate was rudimentary or absent. Castration of vehicle-exposed mice caused far greater reductions in prostate lobe weights, epithelial cell height, and androgen-dependent gene expression (MP25 and probasin) in young mice than in senescent ones, while cell proliferation was decreased by castration in young mice and increased in senescence. Responses to castration were similar at 100 days of age in vehicle- and TCDD-exposed mice. At 510 days, however, TCDD-exposed mice were substantially more responsive to castration by most indices than vehicle-exposed mice. These results demonstrate that prostatic androgen dependence in mice declines substantially with age in several key ways, and that in utero and lactational TCDD exposure protects against this decline. Surprisingly, TCDD increased the incidence of cribriform structures in dorsolateral prostate ducts, from 2-3% in vehicle-exposed senescent mice to 16% in sham-castrated and to 7% in castrated senescent mice. Collectively, these results demonstrate that effects of in utero and lactational TCDD exposure on the prostate persist into senescence, and suggest that in utero and lactational TCDD exposure retards the aging process in the prostate. However, because cribriform structures are often considered to be associated with prostate carcinogenesis, these results also suggest that TCDD exposure early in development may increase susceptibility to prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888670     DOI: 10.1093/toxsci/kfi189

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  12 in total

Review 1.  Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia.

Authors:  Vatsal Mehta; Chad M Vezina
Journal:  Differentiation       Date:  2011 Nov-Dec       Impact factor: 3.880

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin has both pro-carcinogenic and anti-carcinogenic effects on neuroendocrine prostate carcinoma formation in TRAMP mice.

Authors:  Robert W Moore; Wayne A Fritz; Andrew J Schneider; Tien-Min Lin; Amanda M Branam; Stephen Safe; Richard E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-03       Impact factor: 4.219

3.  In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood.

Authors:  William A Ricke; Calvin W Lee; Tyler R Clapper; Andrew J Schneider; Robert W Moore; Kimberly P Keil; Lisa L Abler; Jalissa L Wynder; Arnaldo López Alvarado; Isaac Beaubrun; Jenny Vo; Tyler M Bauman; Emily A Ricke; Richard E Peterson; Chad M Vezina
Journal:  Toxicol Sci       Date:  2016-02-09       Impact factor: 4.849

Review 4.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

Review 5.  AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration.

Authors:  Lijoy K Mathew; Michel T Simonich; Robert L Tanguay
Journal:  Biochem Pharmacol       Date:  2008-09-30       Impact factor: 5.858

Review 6.  AHR signaling in prostate growth, morphogenesis, and disease.

Authors:  Chad M Vezina; Tien-Min Lin; Richard E Peterson
Journal:  Biochem Pharmacol       Date:  2008-10-14       Impact factor: 5.858

7.  2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits fibroblast growth factor 10-induced prostatic bud formation in mouse urogenital sinus.

Authors:  Chad M Vezina; Heather A Hardin; Robert W Moore; Sarah H Allgeier; Richard E Peterson
Journal:  Toxicol Sci       Date:  2009-10-04       Impact factor: 4.849

8.  The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice.

Authors:  Wayne A Fritz; Tien-Min Lin; Stephen Safe; Robert W Moore; Richard E Peterson
Journal:  Biochem Pharmacol       Date:  2008-12-31       Impact factor: 5.858

9.  Estrogen signaling is not required for prostatic bud patterning or for its disruption by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Sarah Hicks Allgeier; Chad M Vezina; Tien-Min Lin; Robert W Moore; Allen E Silverstone; Motoko Mukai; Jerrie Gavalchin; Paul S Cooke; Richard E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-10       Impact factor: 4.219

10.  In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure exacerbates urinary dysfunction in hormone-treated C57BL/6J mice through a non-malignant mechanism involving proteomic changes in the prostate that differ from those elicited by testosterone and estradiol.

Authors:  Anne E Turco; Samuel Thomas; LaTasha K Crawford; Weiping Tang; Richard E Peterson; Lingjun Li; William A Ricke; Chad M Vezina
Journal:  Am J Clin Exp Urol       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.